ClinicalTrials.gg
CompletedNCT06240858Updated Feb 6, 2024

Clinical Study of Self-gripping Mesh in TAPP Versus Lichtenstein Hernia Repair

An interventional study of Laparoscopic transabdominal preperitoneal hernia repair. and Lichtenstein hernia repair. in Inguinal Hernia, sponsored by Second Hospital of Jilin University. Completed at 1 site in China. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-06.

Sponsored by Second Hospital of Jilin University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year 10 months after the study started (first participant enrolled Mar 2022, registered Jan 2024).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 27 studies in Hernia, Inguinal with a site in China — 5 open to participants now, 5 under way, none of them phase 3. Hernia, Inguinal · China.

Enrollment
12th of 24
130 · median 117
Started
2022
with 2 others
No phase
20 of 27
5 open now
Registered
20th of 27
by date
Lead sponsor
2 of 27
Second Hospital of Jilin University

Among the 27 studies in Hernia, Inguinal with a site in China, this one is the 12th largest by enrollment of the 24 interventional ones that give a count, is one of 3 that started in 2022, is one of 20 with no phase, and was the 20th registered.

Hernia, Inguinal

545 studies on the registry are indexed under Hernia, Inguinal; 91 are open to participants now.

Browse Hernia, Inguinal studies →

Open to participants now

5 of the 27 studies in Hernia, Inguinal with a site in China are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 54 Hernia, Inguinal studies recruiting now, 30 (56%) set no upper age limit and 16 (30%) stop at 75 or younger; 16 take children under 18; 9 take healthy volunteers.

This study: 18 Years and older · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Hernia, Inguinal with a site in China, or all of them as a file.
02

Study summary

The goal of this prospective study is to compare the clinical efficacy of self-gripping mesh in laparoscopic transabdominal preperitoneal versus Lichtenstein hernia repair, in order to improve the outcome of inguinal hernia treatment. The main question it aims to answer is, in which procedure is the self-gripping mesh more effective.

Participants will be divided into the TAPP group and the Lichtenstein group by random number table method, the TAPP group underwent laparoscopic transperitoneal preperitoneal hernia repair, and the Lichtenstein group underwent Lichtenstein hernia repair, both groups used self-gripping meshes.

Researchers will compare the operation time, postoperative time out of bed, postoperative hospital stay, hospital costs and postoperative complications between the two groups to see the clinical efficacy of self-gripping mesh in laparoscopic transabdominal preperitoneal versus Lichtenstein hernia repair.

03

Conditions studied

  • Inguinal Hernia

Browse trials for

Keywords

  • Self-gripping mesh
  • Laparoscopy
  • Herniorrhaphy
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male patients aged 18 years and older.
  • Patients with a definite diagnosis of unilateral primary inguinal hernia.
  • Patients and their families were informed about the study protocol and agreed to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Patients with femoral, recurrent, bilateral, incarcerated and strangulated hernias.
  • Patients with previous history of lower abdominal surgery.
  • Patients with to anaesthesia.
  • Patients with contraindications to laparoscopic surgery.
  • Failure to follow up patients as scheduled.
  • Patients with abdominal infections.
  • Those who cannot tolerate general anaesthesia surgery due to serious coagulation disorders, cardiopulmonary disorders, etc.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
130 participants (actual)

Study arms

  • Experimental
    TAPP group

    The TAPP group underwent laparoscopic transperitoneal preperitoneal hernia repair.

    Procedure: Laparoscopic transabdominal preperitoneal hernia repair.

  • Experimental
    Lichtenstein group

    The Lichtenstein group underwent Lichtenstein hernia repair.

    Procedure: Lichtenstein hernia repair.

Interventions

  • ProcedureLaparoscopic transabdominal preperitoneal hernia repair.

    The TAPP group used self-gripping mesh for laparoscopic transperitoneal preperitoneal hernia repair.

  • ProcedureLichtenstein hernia repair.

    The Lichtenstein group used self-gripping mesh for Lichtenstein hernia repair.

06

What researchers measure

Primary outcomes

  1. Incidence of moderate to severe pain at 3 and 6 months after surgery.

    Visual analogue scale (VAS) was used to score the postoperative pain at 3 and 6 months. The score ranges from 0 (no pain) to 10 (most severe pain).

    Time frame: 3 and 6 months after surgery.

Secondary outcomes

  1. Incidence of recurrent inguinal hernia at 3 and 6 months after surgery.

    Recurrence of inguinal hernia after surgery

    Time frame: 3 and 6 months after surgery.

07

Study locations

1 site
  • The Second Hospital of Jilin University
    Changchun, Jilin 130022, China
08

References and documents

Individual participant data

Plan to share: No — Data sharing with other researchers is not planned at this time due to patient privacy concerns.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2022 to primary completion in Nov 2023, 20 months.

Of 179 non-industry interventional studies with no phase under Hernia, Inguinal, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's 20 months is close to that.

Counting every sponsor, half of 188 studies reached it within 19 months; a quarter within 9 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 26, 2024
First posted
Feb 5, 2024
StartActual
Mar 1, 2022
Primary completionActual
Nov 30, 2023
CompletionActual
Nov 30, 2023
Last update
Feb 6, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06240858
Lead sponsor
Second Hospital of Jilin University
Responsible party
Sponsor
First posted
Feb 5, 2024
Start date
Mar 1, 2022
Primary completion
Nov 30, 2023
Completion
Nov 30, 2023
Last update
Feb 6, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion